Association between testosterone and serum soluble α-klotho in U.S. males: a cross-sectional study
2022 · BMC Geriatrics · 37 citations
https://doi.org/10.1186/s12877-022-03265-3
X
Xianghong Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
765
Citations
17
h-index
29
i10-index
Xianghong Zhou is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Prostate Cancer Diagnosis and Treatment & Prostate Cancer Treatment and Research. The author has an h-index of 17, co-authored 71 publications.
ORCID: 0000-0002-2483-2472Papers by this author
worksCysteinyl leukotriene receptor type 1 (CysLT1R) antagonist zafirlukast protects against TNF-α-induced endothelial inflammation
2018 · Biomedicine & Pharmacotherapy · 33 citations
https://doi.org/10.1016/j.biopha.2018.12.064
Intelligent medicine in focus: the 5 stages of evolution in robot-assisted surgery for prostate cancer in the past 20 years and future implications
2024 · Military Medical Research · 19 citations
https://doi.org/10.1186/s40779-024-00566-z
Trends in the global, regional, and national burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data
2024 · International Journal of Surgery · 16 citations
https://doi.org/10.1097/js9.0000000000001603
Comparative Effectiveness of Radiotherapy versus Focal Laser Ablation in Patients with Low and Intermediate Risk Localized Prostate Cancer
2020 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-020-65863-8
An artificial intelligence method for predicting postoperative urinary incontinence based on multiple anatomic parameters of MRI
2023 · Heliyon · 7 citations
https://doi.org/10.1016/j.heliyon.2023.e20337
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat